A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

The influenza (flu) virus affects millions of Americans each fall, winter and early spring, causing doctor visits, ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV -- ...